Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5887727 | Seminars in Arthritis and Rheumatism | 2013 | 7 Pages |
Abstract
In our cohort, no clinical manifestation or disease score could clearly select patients with subsequent lymphoma development. Presence of IgM-kappa clonal components and development of purpura, PNP, and GN should alert the clinician for the presence of lymphoma.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Anna P. MD, Aike A. MD, PhD, Johannes W.J. MD, PhD,